Inactivation of hepatitis B virus CCCDNA using engineered transcription activator-like affector nucleases
Hepatitis B virus (HBV) is a major global public health burden, with over 350 million people chronically infected. This results in approximately 600,000 liver cancer-related deaths annually. Chronic HBV infections are normally managed with long-term anti-HBV therapeutics, such as reverse transcripti...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | en |
| Published: |
2014
|
| Subjects: | |
| Online Access: | http://hdl.handle.net10539/14420 |